This is believed to be the 58th reported case of Listeria monocytogenes infective endocarditis. Published reports worldwide were reviewed as to treatment, outcome, and prognostic features. There is controversy over whether all patients with this condition should have surgery. Moreover the best antibiotic treatment is not known, which accounts for the heterogeneity of regimens used. Listeria endocarditis has a high mortality rate (37%). This was higher in men (41% v 32%) and in patients with valve prostheses (41% v 31%), though neither observation reached statistical significance. There was no significant difference in mortality between surgical and non-surgical treatment, but untreated listeria endocarditis proved universally fatal. From the data, treatment with ampicillin is recommended, with resort to surgery in cases where the infection cannot be eradicated or where haemodynamic compromise has occurred.
monly on prosthetic valves. Since the first report in 1955 by Hoeprichl only 57 cases have been reported worldwide. There seems to be no consensus as to whether surgical treatment confers extra benefit in addition to antibiotic treatment alone. Despite the known sensitivity of L monocytogenes to penicillin, a wide range of antibiotic regimens has been used. We present a further case report of L monocytogenes prosthetic valve endocarditis, and review the world literature in an attempt to determine whether one antibiotic regimen is superior to others, and whether surgery, even in the context of an infected valve, is a necessary adjunct to antibiotic treatment. We also assess the efficacy of different antibiotic regimens and the mortality with antibiotic and surgical treatment where the disease affects prosthetic or diseased valves as well as previously normal valves.
Case report A 78 year old woman who had a Starr Edwards mitral valve replacement 10 years previously presented to her district general hospital with a one month history of malaise, pyrexia, shortness of breath, and purulent sputum. On questioning she admitted to weight loss but not to night sweats. Two weeks previously she had been treated with a course of cephalexin for a presumed chest infection, but showed no improvement. Her only other treatment was digoxin 0 125 mg daily for atrial fibrillation. On examination she had facial plethora, a temperature of 38 8°C, and a solitary splinter haemorrhage on her left foot. Cardiovascular examination showed an irregularly irregular pulse at a rate of 80 beats/min and blood pressure was 160/90 mm Hg. There was an ejection systolic murmur loudest at the left sternal edge. The jugular venous pressure was raised to 6 cm and she had mild bilateral ankle oedema. The slow atrial fibrillation resolved on reducing the dose of digoxin and she continued to improve clinically. Her ESR fell to 10 mm in the first hour, while the first estimation of C reactive protein two weeks into the treatment was found to be less than 5 IU/l. (Berenguer 199148) 55 (Segura 199249) 56 (Lifshitz 19935°) 57 (Speeleveld 19945 seated mitral prosthesis with no evidence of a paravalvar leak. There was mild to moderate aortic regurgitation. Two small echogenic masses were seen on the ball of the Starr Edwards prosthesis. She was treated with intravenous ampicillin and gentamicin for six weeks. She remained in hospital for a further week. Off antibiotics she remained well, her ESR and C reactive protein remain low, and a repeat transoesophageal echocardiogram could not detect the previously noted masses. Eighteen months later she was alive and well.
Review of published reports For our literature search, the Silver Platter Medline identified many of the cases. Others were found in references from previous reports, and in some cases we used the Index Medicus. Statistics were carried out using the Statsview package. We found reports of 57 cases. Some of the information in these reports is rather limited. The main points of interest in each case are shown in table 1.
The mean age of patients was 53 years (range 10 to 83). More males were affected, with a male to female ratio of 1 -6: 1. Mortality was 37% (males 41%, females 32%) which is well over double the figure of 14% quoted by Bayliss et al2 as the overall mortality rate from bacterial endocarditis from all causes. Though male mortality was apparently higher than female, the difference was not found to be significant using a x2 test (P = 0.48). Patients who had a previous valve prosthesis had a higher mortality (41 %) than patients without a prosthesis (31%). This difference was not statistically significant (P = 0 68). Table 2 shows the number of patients receiving no treatment, medical treatment only, and what is labelled "surgical treatment" (which includes antibiotic treatment followed by replacement of the affected valve). Of the reported cases only three did not receive any treatment and this proved to be universally fatal (P = 0-045, X2 test). Survival rate was similar in the antibiotic treated group and in those in whom medical treatment was followed by surgery. Since patients were not randomly allocated to treatment, the possibility of bias affecting which patients were selected for surgery must be considered. The selection bias could act in either direction, with either the most severe cases being put forward for surgery or those who are haemodynamically unstable being refused surgery. As can be deduced from table 1, a vast array of antibiotic regimens has been used. Numerous changes took place in many of the patients' treatments through their illness, but we have tabulated the antibiotic regimen that was used for most of the time or that actually effected a cure. In table 3 we have simplified the antibiotic treatments by grouping similar antibiotic regimens together as one category. There is no statistically significant difference in the survival rate by the use of one or the other antibiotic regimen. This reflects the small number of patients in each treatment group. Three different regimens had 100% survival rate, but each group included only one patient. The combination of streptomycin and penicillin produced a survival rate of 73% (8 of 11), while the combination of aminoglycoside and penicillin showed a survival rate of 63% (10 of 16), which was the same as with penicillin alone (7 of I 1). Discussion L monocytogenes endocarditis is rare but an increase in incidence may be expected in view of the increase in the population of patients with valve prostheses, and as HIV infected patients survive longer and increase in numbers. Also the expertise in identifying this infection is growing. A reported mortality of 37% means that this type of infective endocarditis has a grave prognosis. In view of the small number of reported cases, and because of the wide variety of treatments used, it is extremely difficult to ascertain the best course of treatment. We can infer, however, that surgical treatment can be reserved for resistant cases, or in cases where significant valve damage has occurred which results in haemodynamic compromise.
We did not find that any antibiotic treatment was statistically superior to another. Of statistical significance in our results is the fact that untreated listeria endocarditis is universally fatal. The absence of controlled studies is not limited to the endocarditis form of listeriosis but extends to the other syndromes such as septicaemia, meningoencephalitis, and pregnancy related infections. From experimental laboratory studies it has been shown that there is synergism between ampicillin or penicillin and aminoglycosides against L monocytogenes. The combination of streptomycin and penicillin seems to be the treatment resulting in the greatest survival (excluding the three categories with 100% survival, but with only a single patient treated in each of these). This could be a real or a historical difference, as streptomycin was rarely used after 1970. As streptomycin has to be given intramuscularly and has significant ototoxicity and nephrotoxicity, it should be reserved for second line treatment. It seems that a penicillin alone, such as ampicillin, pro-vides the best treatment option. Adding an aminoglycoside does not seem to increase survival despite the synergism shown in the laboratory. Chloramphenicol has been used only twice and both patients survived. This may also prove to be an effective treatment, but as the numbers are so few and because of the well documented toxicity of chloramphenicol, this should be a treatment of last resort.
In summary we have presented another case of prosthetic valve bacterial endocarditis and reviewed the published reports. Listeria endocarditis has a high mortality rate of 37%, compared with 14% for other types of bacterial endocarditis. Anecdotally it had been suggested that patients with listeria endocarditis should have the affected valve replaced. We have not found any evidence to support this belief. Instead we suggest medical treatment with ampicillin if the organism is sensitive in cultures, and reserve surgery for cases where significant disruption of the valve apparatus has occurred, or when the fever is resistant to antibiotics. 
